[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
Archive ::
For Authors::
For Reviewers::
Ethical Code::
Subscription::
Contact us::
Peer Review Process::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 2, Issue 2 (7-2018) ::
Ir J Physiol Pharmacol 2018, 2(2): 107-100 Back to browse issues page
The effect of ampakine Farampator (CX691) on working memory in a rat model of Alzheimer's disease induced by Amyloid beta 1-42
Nazanin Mozafari , Amir Moghadam-Ahmadi , Ali Shamsizadeh , Iman Fatemi , Mohammad Allahtavakoli , Ayat Kaeidi *
3. Department of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Abstract:   (14550 Views)
Background and aim: Alzheimer’s disease (AD) is a neurodegenerative disorder that can cause memory loss, personality changes and unusual behavior. The purpose of this study was to investigate the effect of ampakine Farampator on impairment of working memory in rat model of Alzheimer's disease.
Methods: Forty male Wistar rat (250-300g) were randomly divided into five experimental groups including: Group 1: Sham/control (intra-hippocampal microinjection of phosphate buffer solution (PBS)/1μl); Group 2: Rat model of Alzheimer's disease (intra-hippocampal microinjection of 4μg/1μl amyloid beta 1-42), Groups 3 & 4: Rat model of Alzheimer's disease + Farampator (30 and 300 µg/kg/by oral gavage/ twice per day); Group 5: Rat model of Alzheimer's disease + Farampator vehicle (saline/ by oral gavage / twice per day). Y-maze spontaneous alternation test was used to evaluate the working memory.
Results: Intra-hippocampal injection of amyloid beta 1-42 caused significant defects in working memory in rat model of Alzheimer's disease (p < 0.01). Farampator 300 µg/kg significantly improved working memory task in rat model of Alzheimer's disease (p < 0.05). Farampator 30 µg/kg had no significant effect on working memory impairment in rat model of Alzheimer's disease.
Conclusion: Ampakine farampator can improve the working memory defect in rat model of Alzheimer's disease.
 
Keywords: Alzheimer's disease, Ampakine farampator, Amyloid beta 1-42, Rat, Working memory
Full-Text [PDF 1390 kb]   (2366 Downloads)    
Type of Study: Original Research | Subject: Neuroscience
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mozafari N, Moghadam-Ahmadi A, Shamsizadeh A, Fatemi I, Allahtavakoli M, Kaeidi A. The effect of ampakine Farampator (CX691) on working memory in a rat model of Alzheimer's disease induced by Amyloid beta 1-42. Ir J Physiol Pharmacol 2018; 2 (2) :107-100
URL: http://ijpp.phypha.ir/article-1-294-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 2 (7-2018) Back to browse issues page
مجله فیزیولوژی و فارماکولوژی ایران Iranian Journal of Physiology and Pharmacology
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4710